Research To Practice im Vergleich zu OncoAir Nutzung und Statistiken

Research To Practice’s CME/CNE accredited activities provide comprehensive perspectives on emerging cancer research and practical management strategies for practicing oncology clinicians. Featuring audio, video and slide-based formats edited by Dr Neil Love, RTP’s programs bridge the gap between clinical research and patient care. Key Features: - Sort educational activities by recent releases or by tumor type - View “Dr Love’s Picks” - Listen to audio or read text excerpts* - Watch webcasts, symposia proceedings and investigator presentations - Review slide sets - View upcoming events moderated by Dr Love - CME and CNE accredited - All content is free * Text not available on all programs
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

OncoAir™ enables authorized OncoEMR® users to continue providing high-quality care while on-the-go. With OncoAir™ you can quickly get up to speed on a patient and take action in real-time while away from your computer. As a clinician, you now have ability to write scripts, upload text notes, and even capture photos to upload to the patient chart right from the app. With OncoAir™, patient information is available at your fingertips with access to patients’ treatment histories, current medications, lab histories, active allergies, visit notes, and all other documents. Please contact your oesupport@flatiron.com if you have questions about your practice's access to the app.
  • Apple App Store
  • Kostenlos
  • Medizin

Rang speichern

- -

Research To Practicevs. OncoAir Ranking-Vergleich

Vergleichen Sie Research To Practice den Ranking-Trend der letzten 28 Tage mit OncoAir

Rang

Keine Daten verfügbar

Research To Practice im Vergleich zu OncoAir Ranking im Ländervergleich

Vergleichen Sie Research To Practice den Ranking-Trend der letzten 28 Tage mit OncoAir

Keine Daten zum Anzeigen

Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an

Los geht's
Research To Practice VS.
OncoAir

Dezember 19, 2024